Fact-checked by Grok 2 weeks ago

Novaluron

Novaluron is a synthetic benzoylurea insecticide that acts as an insect growth regulator (IGR) by selectively inhibiting chitin synthesis in the exoskeletons of immature insects, thereby preventing molting and leading to their death without directly affecting adult insects or mammals. Its chemical structure, with the formula C₁₇H₉ClF₈N₂O₄ and IUPAC name 1-[3-chloro-4-(1,1,2-trifluoro-2-trifluoromethoxyethoxy)phenyl]-3-(2,6-difluorobenzoyl)urea, contributes to its low water solubility (0.003 mg/L at 20°C) and high lipophilicity (log P = 4.3), making it suitable for targeted foliar applications. Primarily used in agriculture and horticulture, novaluron effectively controls a range of pests including lepidopterans (e.g., armyworms), coleopterans (e.g., leaf beetles), dipterans (e.g., leafminers and ), and hemipterans (e.g., ) on crops such as potatoes, apples, , ornamentals, and glasshouse . It is typically formulated as an emulsifiable concentrate and applied as a spray, with efficacy stemming from ingestion by larvae rather than contact, allowing integration into (IPM) programs due to its reduced impact on beneficial like pollinators. Novaluron exhibits low to mammals, with an oral LD₅₀ >5000 mg/kg and dermal LD₅₀ >2000 mg/kg in rats, and it is not classified as mutagenic, carcinogenic, or a reproductive , earning it reduced-risk status from the U.S. Agency upon its conditional registration in 2001 for non-food uses, later expanded to food crops. However, it poses higher risks to aquatic organisms, with NOEC values as low as 0.006 mg/L for , necessitating careful application to avoid environmental contamination; its ranges from 9 days in lab conditions to 96 days in the field, with low potential. Recent studies have also explored its role in for controlling dengue vector mosquitoes like Aedes aegypti, highlighting its versatility beyond .

Overview

Chemical identity

Novaluron is classified as a benzoylphenyl that functions as an (IGR), specifically targeting the inhibition of synthesis in . Its molecular formula is \ce{C17H9ClF8N2O4}, with a molecular weight of 492.7 g/mol. The IUPAC name is 1-[3-chloro-4-(1,1,2-trifluoro-2-trifluoromethoxyethoxy)phenyl]-3-(2,6-difluorobenzoyl), and it has the 116714-46-6. Common synonyms include Rimon and . Structurally, novaluron consists of a benzoyl core featuring a central linkage between a 2,6-difluorobenzoyl moiety and a phenyl ring substituted with a atom at the 3-position and a 1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy group at the 4-position; this configuration contributes to its as a .

Applications and formulations

Novaluron is primarily used as an to control lepidopteran pests such as armyworms, , and codling moths; coleopteran pests including Colorado beetles and beetles; and hemipteran pests like bugs, stink bugs, and . It targets immature stages of these insects on various crops, including , , tomatoes, peppers, cucurbits, , , apples, and ornamentals. Application methods for novaluron include foliar sprays, soil treatments, and baits, typically applied via ground or aerial equipment. Common rates range from 0.024 to 0.12 kg per , depending on the crop and pest; for example, 0.05 kg ai/ha is used on and apples, while higher rates up to 0.1 kg ai/ha apply to potatoes. Novaluron is available in several formulations to suit different application needs, including emulsifiable concentrates (EC) such as 10% EC (100 g/L), suspension concentrates (SC), and wettable powders (WP). Bait formulations, like 0.75% baits or 0.2% granular baits, are used for targeted control in certain scenarios. In (IPM) programs, novaluron plays a key role due to its selectivity for larval and stages, minimizing impact on beneficial and reducing reliance on broad-spectrum pesticides. Its , which disrupts synthesis in immature , complements other control strategies without promoting rapid development. Globally, novaluron has been approved for use in the United States since 2001 on specified crops, with ongoing registrations for expanded applications. In the , approvals were discontinued in 2012 following voluntary withdrawal of the application. It remains authorized in regions including , (e.g., ), (e.g., , ), and .

History and regulation

Development timeline

Novaluron was developed by Makhteshim-Agan Industries Ltd. (now ) in the late as part of broader research into benzoylurea insect growth regulators (IGRs) aimed at providing selective control over pests. This effort was driven by the emerging resistance of insect populations to conventional insecticides, such as organophosphates, which had reduced the efficacy of traditional pest management strategies and prompted the search for novel compounds that target specific stages of insect development. Initial synthesis of novaluron took place around 1996–1998, building on earlier benzoylurea discoveries to optimize structures for enhanced insecticidal activity against lepidopteran and other larval pests. Key patents for novaluron and related benzoylurea compounds were filed in the ; these protections generally expired between 2015 and 2020, allowing for wider production post-patent. Field trials commenced in the early to evaluate novaluron's efficacy in agricultural settings, focusing on its safety profile and performance against target pests in crops like fruits and . These trials supported the compound's progression toward commercialization, with the first launches occurring in and select international markets by 2000 under the brand name Rimon. By 2001, registration applications were submitted , leading to approval for crop protection uses in 2003.

Regulatory approvals and restrictions

In the United States, the Environmental Protection Agency (EPA) established initial tolerances for novaluron residues in and potatoes in December 2001. EPA registration for novaluron products was finalized on December 24, 2003. These tolerances were expanded in 2004 to include fruits, byproducts, and other commodities. In the , novaluron was first applied for inclusion under Directive 91/414/EEC in 2001, with the serving as the . Temporary approvals were granted by s and extended until July 2011 via Commission Decision 2009/579/EC. However, following the applicant's withdrawal of support, novaluron was not included in Annex I by Commission Implementing Decision 2012/187/EU on April 4, 2012, leading to discontinuation of authorizations across the EU. Novaluron received regulatory approvals in several other countries, including in 2004 by the Pest Management Regulatory Agency (PMRA), in 2005 by the Australian Pesticides and Veterinary Medicines Authority (APVMA), and in 2006 by the Ministry of Agriculture, Forestry and Fisheries (MAFF). It is also approved for use in and , with ongoing registrations in many non-EU countries as of 2025. Key restrictions include its prohibition in the EU following the applicant's withdrawal of support. In the US, EPA labels for novaluron products require pollinator protection measures, such as avoiding applications on blooming crops when bees are actively foraging, and mandate 25-foot vegetative buffer zones near aquatic habitats to minimize runoff. Internationally, the World Health Organization (WHO) classifies novaluron as "U" (unlikely to present an acute hazard) in normal use. The Codex Alimentarius Commission has established maximum residue limits (MRLs) for novaluron, including 0.5 mg/kg for cotton seed, adopted in 2006.

Chemical properties

Synthesis

Novaluron is synthesized industrially through a multi-step process that builds the substituted intermediate before forming the characteristic benzoylurea core. The process begins with the chlorination of p-nitrophenol using and at 35–40°C for 3–4 hours, yielding 2-chloro-4-nitrophenol in approximately 80% yield. The second step involves the of the phenolic oxygen to perfluorovinyl methyl ether (CF₂=CF–O–CF₃) in the presence of a mineral base such as , conducted at –10 to 10°C for 5–10 hours in a mixture of and a polar solvent like . This attaches the 1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy group to the ring, producing 2-chloro-4-nitro-1-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]benzene with yields ranging from 61.4% to 89%. In the third step, the nitro group is selectively reduced to an using hydrate and a catalyst (e.g., PdCl₂) under conditions for 24 hours, affording 3-chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy] in 83–85.8% yield. Although gas with catalyst is an alternative reduction method reported in literature for similar intermediates, offers advantages in scalability by avoiding high-pressure equipment. The final step couples the aniline with 2,6-difluorobenzoyl isocyanate at –10 to 20°C for 1–10 hours to form the urea linkage, yielding novaluron in 67.8–85% with overall industrial process efficiency exceeding 80%. The benzoyl isocyanate is prepared separately from 2,6-difluorobenzoyl chloride via reaction with an alkali metal cyanate or from 2,6-difluorobenzamide using oxalyl chloride. The key urea formation can be represented as: \text{Ar-NH}_2 + \text{Ar'-C(O)-N=C=O} \rightarrow \text{Ar-NH-C(O)-NH-C(O)-Ar'} where Ar is the substituted phenyl and Ar' is 2,6-difluorophenyl. Alternative routes to the urea bridge employ phenyl , such as converting the substituted to 3-chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]phenyl and reacting it with 2,6-difluorobenzamide under similar conditions, offering flexibility for laboratory-scale preparations while maintaining high purity. These methods ensure the process is scalable and cost-effective, with raw materials readily available and operations avoiding hazardous intermediates where possible.

Reactivity and stability

Novaluron demonstrates considerable chemical stability under neutral aqueous conditions, remaining largely undegraded at pH 5 and pH 7 over extended periods at 25°C, consistent with half-lives exceeding one year in these media. In alkaline environments, however, it undergoes slow hydrolysis at pH 9 and 25°C, with a half-life of 101 days (rate constant 0.006846 days⁻¹), primarily via cleavage of the amide bond. This reactivity stems from the susceptibility of its central urea linkage to nucleophilic attack by hydroxide ions. Photostability assessments reveal moderate persistence under exposure, with Novaluron exhibiting a (DT₅₀) of 31.1 days in natural under simulated conditions (spring spectrum). Photolytic breakdown in aqueous solutions at 5 proceeds slowly, yielding a DT₅₀ of 139 days under natural summer at 40°N with 12 hours of daily . The fluorinated substituents in its contribute to this relative resistance to , though defluorination pathways may occur over time. Thermally, Novaluron is stable up to its of 176.5–178.0°C (for 99.5% purity material), beyond which is not explicitly quantified but occurs under elevated temperatures, as inferred from accelerated studies showing half-lives of 1.2 days at 50°C and 0.09 days at 70°C in alkaline media. It shows no oxidizing properties and is non-flammable under standard conditions. Novaluron's solubility profile underscores its lipophilic nature, with very low solubility of 3 µg/L at 20°C and neutral , limiting its mobility in aqueous systems. In contrast, it dissolves readily in organic solvents, including 198 g/L in acetone and 113 g/L in at 20°C, facilitating in non-aqueous carriers. The log Kₒw value of 4.3 (at 20–25°C, 7.1) further confirms high , promoting partitioning into organic phases and biological while resisting rapid aqueous dispersal.

Biological activity

Mechanism of action

Novaluron is classified as a benzoylphenyl and functions primarily as an inhibitor of synthesis in the exoskeletons of , targeting larval and stages during their molting processes. By interfering with this essential biochemical pathway, novaluron prevents the proper formation of the rigid -based cuticle required for development and survival. At the molecular level, novaluron inhibits chitin synthase 1 (CHS1), disrupting the of UDP-N-acetylglucosamine (UDP-GlcNAc) into . This inhibition halts the synthesis of in ectodermal tissues, leading to malformed cuticles and failed . As a non-systemic (IGR), novaluron exerts its effects through ingestion or contact, with primary activity observed after uptake by actively feeding immatures. The disruption results in incomplete molting, where larvae or nymphs are unable to shed their old exoskeletons properly, culminating in abnormal cuticles and death typically within 3 to 7 days post-exposure. Novaluron's selectivity stems from its focus on ecdysteroid-regulated chitin deposition, which is prominent during the molting cycles of immature but minimal in or organisms lacking , such as vertebrates. This targeted action spares most adult and beneficial arthropods, enhancing its utility in . Regarding resistance, novaluron exhibits low cross-resistance to neurotoxic due to its distinct on . Resistance is primarily monitored through target-site in the synthase 1 (CHS1) , such as the conserved I1042M , which reduces binding affinity without broadly impacting other classes. Recent studies (as of 2024) have confirmed the I1042M in CHS1 as a key resistance mechanism to novaluron and related benzoylureas in lepidopteran pests.

Metabolism and biotransformation

Novaluron exhibits low oral in mammals, with studies in rats showing approximately 6-7% for the chlorophenyl-labeled compound and up to 20% for the difluorophenyl-labeled compound at a dose of 2 mg/kg body weight, decreasing further at higher doses such as 1000 mg/kg. The absorbed portion undergoes extensive primarily through oxidative cleavage of the bridge linking the chlorophenyl and difluorophenyl moieties, involving P450-mediated processes. Key metabolites include 3-chloro-4-(1,1,2-trifluoro-2-trifluoromethoxyethoxy) (3-TFA) and 2,6-difluorobenzoic , with up to 15 minor metabolites identified in and , each representing less than 1% of the administered dose. Of the absorbed novaluron, 80-90% is rapidly metabolized and excreted in within 48 hours, while the majority of the unabsorbed parent compound (over 86-95%) is eliminated unchanged in . The profile in rats indicates low systemic due to poor and rapid clearance, with distribution primarily to lipophilic tissues such as fat, liver, and kidneys, where concentrations are highest. Terminal elimination is approximately 52-56 hours in fat following repeated dosing, but overall is shorter in and most tissues, with less than 1.6% retention after 7 days and no evidence of owing to efficient . Defluorination occurs as a minor pathway, contributing to the formation of fluorinated metabolites like 2,6-difluorobenzoic acid. In , novaluron is primarily taken up via the gut following , with some contact activity, leading to accumulation in the where it interferes with synthesis during molting. Limited data exist on in , though the parent compound remains the primary active form in target tissues. Rapid uptake and localized accumulation in the contribute to its selectivity for immature stages, without significant due to the compound's targeted action on developmental processes.

Efficacy

Novaluron exhibits high efficacy against a range of target pests, achieving greater than 90% control in many cases, particularly for larval stages of the Colorado potato beetle (Leptinotarsa decemlineata), leafminers, whiteflies (Bemisia tabaci), armyworms (Spodoptera spp.), and bollworms (Helicoverpa zea) on crops such as cotton and potatoes. Field evaluations on cotton have confirmed its effectiveness against bollworms, with significant larval suppression when applied at recommended rates. Similarly, label registrations highlight its use for controlling whiteflies and armyworms on vegetables and cotton, emphasizing ingestion or contact for optimal results. Application rates of 0.05–0.1 kg per result in 80–100% larval mortality for susceptible species, targeting the synthesis process during molting as detailed in its . Ovicidal effects are limited overall, though novaluron suppresses egg hatch in certain species, such as bollworms on , where topical exposure reduces hatch rates by disrupting eggshell formation. U.S. field trials from the 2000s demonstrated 85–95% reduction in lepidopteran damage on cole crops and , with novaluron outperforming untreated controls in larval density and protection. However, is lower (<70%) against certain stem borers, such as Diatraea saccharalis, due to their internal feeding behavior limiting exposure, though reductions up to 99% injury prevention were observed in some Louisiana sugarcane experiments. Rotational use of novaluron is recommended in integrated pest management (IPM) programs to mitigate resistance risks, with no widespread resistance reported as of 2025 across monitored populations. Compared to pyrethroids, novaluron offers superior selectivity in IPM owing to its stage-specific action on immatures, reducing broad-spectrum impacts. It also shows synergy with Bacillus thuringiensis, requiring only half the novaluron rate to achieve 90% larval mortality in diamondback moth (Plutella xylostella).

Safety and environmental impact

Toxicity to mammals

Novaluron demonstrates low acute toxicity to mammals across all major exposure routes. In rats, the oral median lethal dose (LD50) exceeds 5000 mg/kg body weight, indicating minimal risk from ingestion. Dermal application results in an LD50 greater than 2000 mg/kg body weight in rats and rabbits, while the inhalation LC50 in rats surpasses 5.15 mg/L air over a 4-hour exposure period. Chronic exposure studies reveal a no-observed-adverse-effect level (NOAEL) of 1.1 mg/kg body weight per day in a 2-year rat feeding study, based on hematological alterations such as reduced erythrocyte counts at higher doses. The acceptable daily intake (ADI) for humans is established at 0–0.01 mg/kg body weight, derived from this NOAEL with safety factors. Novaluron shows no evidence of carcinogenicity in long-term studies with rats and mice, nor does it exhibit mutagenicity or genotoxicity. Reproductive and developmental toxicity are absent in multi-generation rat studies and rabbit teratology assays up to limit doses of 1000 mg/kg body weight per day. At elevated doses, such as 7000 ppm in chronic rat studies, mild centrilobular hepatocyte hypertrophy in the liver has been noted, alongside secondary splenic effects. Novaluron is non-irritating to rabbit skin and eyes and does not act as a skin sensitizer in guinea pigs. Human exposure primarily occurs through dietary residues, presenting low risk due to rapid metabolism that limits systemic availability; established maximum residue limits (MRLs) ensure chronic dietary intake remains well below the ADI, typically less than 1% for most populations.

Effects on non-target organisms

Novaluron exhibits low acute toxicity to adult beneficial insects, such as honey bees, with an oral LD50 exceeding 100 µg/bee, indicating minimal direct risk to pollinators from contact or ingestion during application. However, sublethal effects have been observed on larval stages of predatory insects, including coccinellids like ladybird beetles, where topical exposure results in 40-63% mortality in early instars due to inhibition of chitin synthesis, potentially disrupting biological control in integrated pest management (IPM) systems. Field studies on leafminer pests have shown that novaluron reduces the efficacy of parasitoids, such as those in the genus Neochrysocharis, by negatively impacting immature parasitoid stages through direct or indirect exposure, leading to lower emergence rates and compromised IPM outcomes. In silkworm (Bombyx mori), a non-target lepidopteran, novaluron causes significant negative impacts at field application rates, including integument rupture, feeding cessation, delayed development, and reproductive toxicity such as impaired ovary and testis formation, resulting in reduced oviposition and egg hatchability. For avian species, novaluron poses no acute risk, with LD50 values exceeding 2000 mg/kg body weight in species like the northern bobwhite quail, but chronic dietary exposure in reproduction studies yields a NOAEC of 9.8 mg/kg diet, suggesting potential risks to bird populations from repeated environmental exposure. Aquatic non-target organisms face moderate to high risks, particularly invertebrates; novaluron is highly toxic to Daphnia magna, with a 48-hour EC50 of 0.31 µg/L, while showing low toxicity to fish such as bluegill sunfish (96-hour LC50 > 0.96 mg/L). However, chronic toxicity is higher, with a 21-day NOEC of 0.006 mg/L for (Oncorhynchus mykiss). To mitigate impacts on pollinators and beneficial insects, application timing outside peak foraging periods and establishment of buffer zones around water bodies and flowering areas are recommended, reducing drift and residue exposure in agricultural settings.

Environmental fate and persistence

Novaluron demonstrates moderate persistence in under aerobic conditions, with laboratory DT50 values ranging from 4 to 45 days at 20°C and field dissipation half-lives of 18 to 160 days depending on environmental factors such as and . Under conditions, is slower, contributing to its overall persistence in waterlogged soils. The compound binds strongly to carbon, with Koc values typically between 6,000 and 12,000 mL/g, which limits its mobility and results in a low risk of into . In aquatic environments, novaluron hydrolyzes slowly, with a of 101 days at 7 and 25°C, indicating that is not a major pathway under neutral conditions. Degradation in -sediment systems occurs more rapidly, with DT50 values of 10 to 51 days for the whole system and as low as 0.9 to 1.3 days in water alone under aerobic conditions. is negligible due to its low of approximately 3 × 10^{-9} at 25°C, minimizing atmospheric transport. Photodegradation of novaluron proceeds slowly on surfaces, with a DT50 of 257 to 259 days under natural , suggesting limited contribution from this process in terrestrial environments. In , photodegradation half-lives range from 7 to 187 days depending on and light intensity, though some studies indicate stability under aqueous photolysis conditions. Major photodegradates, such as chlorophenyl and chloroaniline derivatives, form but do not pose significant additional risks compared to the parent compound. Bioaccumulation potential in aquatic organisms is low overall, despite high steady-state factors (BCF) of up to 14,000 in fish like , due to rapid metabolic clearance with half-lives of 3.9 to 7.3 days. This prevents long-term accumulation, and the log Kow of 4.3 further supports limited through food chains. Environmental reveals novaluron residues in following application, typically declining to below maximum residue limits (MRLs) within seasons, with accumulation not exceeding 0.46 mg/kg after multiple applications. In surface waters, detections are infrequent and low (maximum 30.9 ng/L), while shows non-detections, aligning with its low mobility profile. Regulatory assessments in regions like the have highlighted concerns over potential from degradates, leading to restrictions on use despite overall low persistence.